# SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

> **NCT00006000** · PHASE1 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** cisplatin
- **DRUG:** irinotecan hydrochloride
- **DRUG:** semaxanib

## Key facts

- **NCT ID:** NCT00006000
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006000, "SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00006000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*